Lancets Market To Reach $9.15 Billion By 2030 | CAGR: 7.7%

Lancets Market Growth & Trends

The global lancets market size is estimated to reach USD 9.15 billion by 2030, registering to grow at a CAGR of 7.7% from 2025 to 2030 according to a new report by Grand View Research, Inc. The market is primarily driven by increasing incidence of infectious diseases, coupled with advancement in the field of diagnostic testing. Furthermore, increasing awareness about self-monitoring of blood glucose, coupled with improved accuracy in self diagnostic among patients, is adding to the market growth.

Rapidly changing lifestyle such as unhealthy food, consumption of alcohol, and lack of physical activities is increasing the incidence of lifestyle associated chronic diseases. Rising government expenditure and technological advancement in the field of diabetes management are expected to drive the market. Furthermore, increasing preference for home care settings and growing trend of using advanced lancet devices, including automatic versions, are some of the factors expected to drive the market during forecast period.

Availability of lancets in different sizes and specifications is expected to increase the usage of these devices by geriatric patients. Growth of the geriatric population across the globe is also opening new avenues for the market. Aged people are more prone to infectious diseases, thereby significantly contributing to the market growth.

 Request a free sample copy or view report summary: Lancets Market Report

Lancets Market Report Highlights

• Safety lancets accounted for the largest share of 56.4% in 2024 as they are easily available compared to other lancets due to their affordability and low exposure to infections enabled by them. This increases the accessibility of safety lancets, driving the segment growth.

• The blood glucose testing segment accounted for the largest market share of 41.1% in 2024. The rising prevalence of diabetes and increasing awareness regarding self-monitoring blood glucose are major factors driving market growth.

• The hospitals and clinics segment dominated the market in 2024. The increasing number of patients who have diabetes and the incidence of infectious diseases and other diseases requiring blood testing kits are majorly driving the segment growth.

Lancets Market Segmentation

Grand View Research has segmented the global lancets market based on type, application, end-use, and region:

Lancets Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Safety Lancets

• Standard Lancets

Lancets Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Blood Glucose Testing

• Hemoglobin Testing

• Cholesterol Testing

• Coagulation Testing

• Infectious Disease Testing

• Others

Lancets End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals and Clinics

• Homecare Settings

• Others

Lancets Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Lancets Market

• BD

• Roche Diagnostics

• Medline Industries, LP.

• EQT AB

• MTD Medical Technology and Devices

• B. Braun SE

• Terumo Medical Corporation

• Owen Mumford

• Arkray

• AgaMatrix

• Nipro Europe Group Companies.